Newsroom

Locks Law Firm partner Jonathan Miller and associate James Barry represented the New Jersey Association for Justice (NJAJ) at the Supreme Court of New Jersey as amici.  As representatives of the NJAJ, the pre-eminent plaintiff/consumer group in the state of New Jersey, they argued how 2 various cases may affect plaintiffs/consumers across the state.

Mr. Miller, whose almost 40 year history of appellate litigation includes being Chief of Appeals of the Defender Association of Philadelphia, argued two timely issues concerning experts: the sufficiency of the evidence and standards for an expert to render opinions concerning motor vehicle accidents, and whether an adverse inference may be drawn if a defendant does not call its expert to testify.

In the most recent Sports Litigation Alert, Janet Lewis, Director of Sports & Athlete Relations, addresses the need for training and planning to prevent heat related injuries in high school and youth sports. The conclusion: Prevent civil and criminal liability by exercising reasonable care for safety under hot and humid conditions. Instruct athletes on safe procedures and warm them of the risks and dangers so that they, too, can recognize signs of heat injury. By providing medical assistance and creating and following an EAP, the liability for those involved can be greatly reduced, along with the injuries themselves.

Partner David Langfitt writes for Sporting Kids: Facemasks help prevent concussions and other serious injuries in young baseball and softball players. Are your players protected when they step in the batter’s box?

Youth Sports and the Law: Using facemasks on batting helmets

Senior Partner Marc Weingarten named Super Lawyer for plaintiff product liability for the 10^th time in 2015.  (Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement. The selection process includes independent research, peer nominations and peer evaluations. – superlawyers.com).  To learn more about Mr. Weingarten’s practice and accomplishments, go to Super Lawyers or view his Locks Law Firm profile.

In his recently published article on mainlinemedianews.com, Attorney David Langfitt discusses the risks associated with concussions and traumatic brain injuries (TBI) in amateur and youth sports.  Drawing attention to policies and steps that should be taken when any athlete suffers a hit or blow to the head, he reminds us that, "we should recognize that the excitement the athletes bring us comes with serious risk and cost – and not one of them is getting paid to perform." 

An injured plaintiff was awarded $155,000 in West Virginia for his Actos-related bladder cancer. The jury was only out three hours before it rendered its verdict. This verdict followed right on the heels of a Philadelphia jury verdict of $2 million to another former Actos user. In the recent trial the judge allowed the lawyer for the plaintiff to argue that defendant, Takeda, intentionally destroyed many of its Actos development and marketing files. The US spokesperson for Takeda said that the company is considering its options, which would include an appeal. There are more than 8,000 Actos cases filed around the country, with over 3,500 filed in federal court (which is where Locks Law Firm LLC files its Actos cases).

A jury in Philadelphia found defendant, Takeda, liable for over $2 million for failing to warn that its drug, Actos, can cause bladder cancer, and for causing a 79-year-old woman's bladder cancer. During the three-week-plus trial,  Takeda had argued that smoking or other causes were to blame. There have now been seven (7) trials involving claims that Actos caused bladder cancer. The largest verdict, $9 billion earlier this year, is being appealed by Takeda. Two verdicts in favor of plaintiffs (California and Maryland) which combined totalled $8.2 million, were overturned by the trial judge. Three verdicts (two in Las Vegas and one in Illinois) were defense verdicts in favor of Takeda. Evidence shows that Takeda officials destroyed documents about Actos. Actos is a Type-2 diabetes drug which  has generated over $16 billion in sales since it was released in 1999. The peak in sales was in the year ending March 2011, at $4.5 billion. Actos accounted for over 25% of Takeda's profits. There are over 3,500 lawsuits consolidated before Judge Rebecca Doherty in federal court in Louisiana. There are another 4,500 cases in state courts in Illinois, Pennsylvania, West Virginia and California.

On the 21st day of March,  Jerry Lindheim, Esquire-partner at the Locks Law Firm was featured on the Dick Morris Afternoon Drive radio broadcast WPHT 1210AM during which time he discussed nursing home neglect and abuse and patient's rights and remedies.

http://www.podtrac.com/pts/redirect.mp3/nyc.podcast.play.it/media/d0/d0/d1/d4/dV/dU/dQ/14VUQ_3.MP3

Please be advised that Locks Law Firm is now accepting referrals of Risperdal cases. Risperdal is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson.  It causes Gynecomastia, the growth of breasts, in males.  Risperdal is a mass tort in the Philadelphia Court of Common Pleas.   The criteria of cases worthy of filing is very simple:  Gynecomastia in males which develops during or shortly after usage of Risperdal.  The patent on Risperdal expired in 2008, at which time generics became available. We will review cases where there was only name brand Risperdal usage and also cases with mixed name brand/generic usage. However, due to rulings of the US Supreme Court, we are not presently reviewing cases with generic use only. If you have been contacted by a man who may have been injured by these products, please contact us. For more information please contact Michael Galpern at 856-663-8200 or Michael Leh at 215-893-0100.

Please be advised that Locks Law firm is currently accepting referrals of Zimmer Durom Cup Hip replacement cases.  The Durom Cup is a hip replacement product, first marketed by Zimmer in the United States in 2006.  The Durom Cup has an unreasonably high incidence of failing to bond with growth of the securing host bone, leading to loosening and movement of the product and requiring a second surgery to remove and replace the Durom Cup product.   There are also incidences of metallosis, or metal poisoning, resulting from the Zimmer Durom Cup product and also requiring removal and replacement of the Durom Cup product.   Zimmer Durom Cup claims are currently coordinated in MDL No. 2158 in the District of New Jersey.